Cargando…
Omicron-specific mRNA vaccine elicits potent immune responses in mice, hamsters, and nonhuman primates
Autores principales: | Wu, Yi, Shen, Yanqiong, Wu, Namei, Zhang, Xinghai, Chen, Shaohong, Yang, Chang, Zhou, Junhui, Wu, Yan, Chen, Da, Wang, Li, Wang, Chao, Zhang, Huajun, Xia, Ninuo, Chiu, Sandra, Wang, Yucai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340695/ https://www.ncbi.nlm.nih.gov/pubmed/35915244 http://dx.doi.org/10.1038/s41422-022-00706-x |
Ejemplares similares
-
A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery
por: Zhang, Xinghai, et al.
Publicado: (2022) -
Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV
por: Wilkins, Jordan, et al.
Publicado: (2016) -
RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates
por: Pan, Xiaoyan, et al.
Publicado: (2021) -
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
por: Ma, Huan, et al.
Publicado: (2022) -
Increased pathogenicity and aerosol transmission for one SARS-CoV-2 B.1.617.2 Delta variant over the wild-type strain in hamsters
por: Zhang, Xinghai, et al.
Publicado: (2022)